KYMERA THERAPEUTICS, INC. (KYMR) /
The revenue of KYMERA THERAPEUTICS, INC. over the past 7 years
Chart KYMERA THERAPEUTICS, INC.: revenue, fiscal 2019–2025 Open the chart →KYMERA THERAPEUTICS, INC. reported revenue of $39.21M in fiscal 2025, the latest fiscal year on file. In fiscal 2019 it was $2.93M — up 1236% over 6 years. Year over year, revenue rose 3 times and fell 3 times. In these years the highest was $78.59M in fiscal 2023. The largest one-year move was in fiscal 2020: up 1060%, from $2.93M to $34.03M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $39.21M |
| 2024ended Dec 31, 2024 | $47.07M |
| 2023ended Dec 31, 2023 | $78.59M |
| 2022ended Dec 31, 2022 | $46.83M |
| 2021ended Dec 31, 2021 | $72.83M |
| 2020ended Dec 31, 2020 | $34.03M |
| 2019ended Dec 31, 2019 | $2.93M |
Fiscal years as KYMERA THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on KYMERA THERAPEUTICS, INC.
- The profitability of KYMERA THERAPEUTICS, INC.
- The cash flow of KYMERA THERAPEUTICS, INC.
- The debt of KYMERA THERAPEUTICS, INC.
- All of KYMERA THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- DDSDILLARD’S, INC.
- HIIHUNTINGTON INGALLS INDUSTRIES, INC.
- ARWARROW ELECTRONICS, INC.
- FNFFIDELITY NATIONAL FINANCIAL, INC.
- BMRNBIOMARIN PHARMACEUTICAL INC
Not investment advice. This page shows what KYMERA THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.